Obsessive-Compulsive Disorder

• Orbitofrontal-Striatal Hyperactivity and Error Detection: The orbitofrontal cortex (OFC) normally signals when current behavior deviates from expected outcomes, triggering course correction. In OCD, hyperactivity in OFC-anterior cingulate cortex (ACC) circuits creates a pathological "error signal" that persists despite appropriate behavioral responses, generating the intrusive thoughts and compulsive urge to verify or ritualize. Neuroimaging shows increased glucose metabolism and resting-state activity in these regions; the medial prefrontal cortex shows reduced inhibitory tone over the amygdala, amplifying threat perception.

• Serotonin-Glutamate Dysregulation: Reduced serotonergic neurotransmission in OFC-striatal circuits is the basis for selective serotonin reuptake inhibitors (SSRIs) efficacy. Simultaneously, excessive glutamatergic signaling at N-methyl-D-aspartate (NMDA) receptors in the striatum drives excessive looping of thought-action cycles; augmentation with glutamate modulators (e.g., riluzole, memantine) shows promise in treatment-resistant cases. The ventral tegmental area and nucleus accumbens show altered dopamine signaling, disrupting reward-based learning and habit extinction—explaining the compulsive, perseverative nature despite absent reinforcement.

• Impaired Response Inhibition and Habit Suppression: The dorsolateral prefrontal cortex (dlPFC) normally exerts top-down inhibition over compulsive behaviors via projections to the subthalamic nucleus and prefrontal striatum. In OCD, reduced dlPFC-striatal connectivity and decreased activity in the anterior cingulate cortex (conflict-monitoring region) impair the ability to suppress habitual responses even when consciously recognizing their irrationality. This explains the ego-dystonia characteristic of OCD—patients know the compulsions are irrational but cannot suppress them.

• Genetic and Epigenetic Factors: Twin studies show heritability of ~40-50% for OCD. Candidate genes include SLC1A1 (glutamate transporter), BDNF (brain-derived neurotrophic factor), and COMT (catechol-O-methyltransferase), which modulate prefrontal dopamine tone. Environmental stressors (trauma, infections, parenting) interact with genetic predisposition; pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS) represent one environmental trigger, though mechanistic links remain debated. Epigenetic alterations in gene expression (DNA methylation patterns) may increase OCD vulnerability.

• Abnormal Threat-Processing and Hyperactive Amygdala: The amygdala shows hyperresponsivity to threat-related stimuli, including contamination, harm, and taboo thoughts. Reduced ventromedial prefrontal-amygdala connectivity impairs extinction learning (the normal decrease in fear response with repeated safe exposure), perpetuating avoidance and compulsive rituals.

• Genetic Predisposition (Primary OCD): ~40-50% heritability; first-degree relatives have 5-10× elevated risk. Specific polymorphisms in SLC1A1, BDNF, and glutamatergic genes increase vulnerability. De novo mutations and copy-number variants have been identified in some families.

• Neurobiological Factors: Baseline serotonergic, dopaminergic, and glutamatergic dysfunction within OFC-striatal-thalamic circuits; structural abnormalities (reduced white matter integrity, altered striatal volume) and functional connectivity disturbances identified via neuroimaging.

• Environmental and Psychological Stressors: Severe life stress, trauma (emotional, physical, sexual abuse), and major life transitions (move, loss) can precipitate or exacerbate OCD in genetically vulnerable individuals. Parenting styles emphasizing perfectionism or threat-sensitivity may increase risk.

• Peripartum and Hormonal Factors: OCD often worsens during pregnancy and postpartum period; hormonal fluctuations (estrogen, progesterone) may modulate serotonergic function. Some cases begin or dramatically worsen postpartum (postpartum OCD).

• Infection-Related Models (PANDAS and PANS): Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS) describe sudden-onset OCD and tics in children following Group A Streptococcal pharyngitis, though causality and prevalence remain controversial. Pediatric acute-onset neuropsychiatric syndrome (PANS) encompasses broader infectious triggers (viral infections, Lyme disease). These mechanisms may involve molecular mimicry (antibodies cross-reacting with neuronal antigens) or direct inflammatory infiltration.

• Comorbid Psychiatric Conditions: Major depressive disorder, generalized anxiety disorder, social anxiety disorder, and body dysmorphic disorder frequently co-occur and may share underlying neurobiology or worsen OCD severity.

• Personality Traits: Perfectionism, harm avoidance, conscientiousness, and need for control are associated with higher OCD risk and may represent stable temperamental risk factors.

Obsessions (Intrusive Thoughts/Images/Urges)

• Contamination Obsessions: Intrusive fears of germs, bodily fluids, or harmful substances (e.g., "If I touch that doorknob, I will contract HIV and infect my family"). Driven by hyperactivity in threat-detection circuits; patients acknowledge the irrationality but cannot suppress the anxiety spike.
• Harm Obsessions: Unwanted mental images of causing harm to self or others (e.g., "I might push someone in front of a train," "What if I hit a pedestrian and didn't notice?"). Critical distinction: OCD patients are deeply distressed and have no desire to harm; intrusive thoughts are ego-dystonic. Risk of actual harm is low.
• Taboo/Aggressive Obsessions: Blasphemous thoughts, violent imagery, or unwanted sexual thoughts (pedophilic or homosexual content in heterosexual individuals). Profound shame and secrecy often delay diagnosis.
• Symmetry and Order Obsessions: Intense need for exactness, matching, or "just-right" feelings. Objects must be aligned perfectly; asymmetry causes marked distress.
• Responsibility Obsessions: Exaggerated sense of responsibility for preventing harm. Patients may ruminate for hours about whether they did something wrong (e.g., "Did I hit someone with my car?").

Compulsions (Repetitive Behaviors/Mental Acts)

• Washing and Cleaning: Repetitive handwashing, showering, or sanitizing surfaces to reduce contamination anxiety. May escalate to skin breakdown (dermatitis) or damage to household materials.
• Checking: Repeatedly checking locks, appliances, or reviewing actions (re-reading emails, replaying events mentally) to verify safety and reduce harm-related anxiety.
• Arranging and Ordering: Organizing objects symmetrically or in specific sequences until achieving a "just-right" feeling; arranging can consume hours.
• Counting and Repeating: Performing actions a specific number of times (often odd numbers or multiples of significant numbers) or counting steps, words, or objects.
• Reassurance-Seeking: Repeatedly asking family members for reassurance that no harm will occur or that specific actions are safe. Temporary relief followed by return of anxiety drives repetition.
• Mental Compulsions: Covert rituals including praying, mental reviewing, substituting "good" thoughts for "bad" ones, or mental checking—equally time-consuming and impairing as overt compulsions.
• Avoidance: Avoidance of triggers (avoiding certain locations, people, or activities associated with obsessions); avoidance maintains OCD by preventing habituation.

Physical Examination Findings

• Skin Findings: Erythema, excoriation, dermatitis, or bleeding from excessive washing and scrubbing (especially hands, forearms).
• Behavioral Observations: Visible ritualistic movements, repetitive checking behaviors, slow processing speed during interview due to internal compulsions, or tangential speech related to rumination.
• Grooming and Appearance: Generally intact (unlike some psychotic or depressed patients), but may show signs of distress or unkemptness if compulsions are time-consuming.
• Affect and Demeanor: Anxiety, shame, or reluctance to disclose obsessional content initially; many patients with taboo obsessions fear being labeled as dangerous or perverted.

Important Clinical Variants

• Primarily Obsessional OCD ("Pure O"): Marked obsessions with minimal visible compulsions; mental rituals and avoidance dominate. Often underrecognized because overt compulsions are absent. Recognition is critical because cognitive-behavioral therapy (CBT) modifications are required.
• Scrupulosity: Religious obsessions (blasphemous thoughts, fear of religious transgression) with extensive praying or confession-seeking. Common in religiously observant populations; requires cultural sensitivity in assessment.
• Hoarding Disorder (as OCD presentation): Compulsive acquisition and inability to discard items, usually with underlying obsessions about wastefulness or loss. (Note: Hoarding disorder is now a separate DSM-5 diagnosis but frequently comorbid with OCD.)
• Body-Focused OCD: Obsessions about body parts (skin imperfections, bodily sensations, asymmetry) with compulsive skin picking, mirror checking, or grooming—overlaps with body dysmorphic disorder and excoriation disorder.
• Relationship OCD: Persistent doubts about the rightness of a romantic relationship, with mental reviewing and reassurance-seeking; high risk of avoidable relationship dissolution if untreated.
• Sexual Orientation OCD: Intrusive sexual obsessions about one's sexual orientation, with compulsive reassurance-seeking and avoidance of opposite-sex relationships; notably distinct from genuine sexual orientation questioning.

Clinical History and Interview

• Thorough timeline of symptom onset, evolution, and current severity. Assess whether obsessions and compulsions are present, their content, triggers, and time consumed (diagnostic threshold: ≥1 hour/day or significant functional interference).
• Screen for ego-dystonia: Ask "Do you recognize these thoughts/urges as coming from your own mind or do they feel imposed?" (OCD = ego-dystonic; distinguish from psychosis where thoughts may be ego-syntonic/alien control).
• Assess insight level: "Do you believe these fears are realistic?" (Good insight = recognizes irrationality; poor insight = believes obsessions are true; this affects prognosis and treatment planning).
• Functional impact: Ask about work/school absenteeism or performance, social withdrawal, relationship strain, and time lost to rituals.
• Screen for hoarding, hair pulling (trichotillomania), skin picking (excoriation disorder), and body-focused repetitive behaviors, which may co-occur.

• Yale-Brown Obsessive Compulsive Scale (Y-BOCS): Gold-standard severity instrument; assesses obsession severity (10 items), compulsion severity (10 items), and functional impairment over past week. Scores range 0-40; ≥16 indicates clinically significant OCD; ≥21 indicates moderate-to-severe OCD. Sensitivity 97%, specificity 85% for OCD diagnosis. Required for baseline and treatment monitoring.
• Obsessive-Compulsive Inventory-Revised (OCI-R): Self-report 18-item screener; faster than Y-BOCS. Cut-off ≥21 suggests OCD (sensitivity 86%, specificity 89%).
• Dimensional Yale-Brown Obsessive Compulsive Scale (DY-BOCS): Assesses specific symptom dimensions (contamination, harm, sexual, religious, symmetry, hoarding, somatic, taboo thoughts, miscellaneous) to guide targeted treatment.

Diagnostic Criteria (DSM-5)

1. 1.Obsessions defined by: (a) recurrent, persistent thoughts, urges, or images that are intrusive and cause anxiety/distress AND (b) person attempts to suppress or ignore them or use other mental acts to neutralize them.
2. 2.Compulsions defined by: (a) repetitive behaviors or mental acts performed according to rigid rules AND (b) aimed at preventing/reducing anxiety or preventing a dreaded outcome (not realistic/proportionate).
3. 3.Time and Functional Criteria: Obsessions or compulsions consume ≥1 hour per day (or significantly interfere with functioning) and cause clinically significant distress or impair occupational, social, or personal functioning.
4. 4.Insight Specifier: Good (recognizes beliefs are definitely/probably not true), Fair (unsure if true), or Poor (believes beliefs are probably/definitely true).
5. 5.Tic-Related Specifier: Note if OCD has current or lifetime tic disorder (10-15% comorbidity; associated with poorer prognosis and different genetic risk).

Laboratory and Imaging

• Routine Labs: No diagnostic laboratory test exists for OCD. Baseline labs (CBC, CMP, TSH) are standard before initiating SSRIs to exclude medical mimics (hyperthyroidism, seizure disorders, neurologic conditions).
• Neuroimaging (MRI, fMRI, PET): Not routinely used for clinical diagnosis but research demonstrates increased OFC and ACC activity, reduced dlPFC volume/connectivity, and striatal abnormalities. Functional neuroimaging may eventually refine phenotyping and predict treatment response but are not standard of care.
• Testing for PANDAS/PANS: Serology for Group A Streptococcus (strep titer) and clinical Strep exposure history; antistreptococcal/antineuronal antibodies (anti-NMDA) in specialized centers for suspected PANS cases—clinical utility remains investigational.

Differential Diagnosis Considerations

• Generalized Anxiety Disorder (GAD): Worry is ego-syntonic (person accepts it); lacks compulsions and intrusive imagery characteristic of OCD. GAD responds less well to SSRIs alone but requires higher doses in OCD.
• Major Depressive Disorder with Rumination: Depressive ruminations are passive, mood-congruent (about failure, worthlessness), and reduce anxiety; OCD obsessions are active, ego-dystonic, and increase anxiety despite compulsions.
• Specific Phobia: Limited to circumscribed feared object/situation; lacks compulsions or obsessions unrelated to phobic triggers.
• Body Dysmorphic Disorder (BDD): Preoccupation with perceived body defects; lacks true obsessions/compulsions (repetitive checking ≠ compulsion in BDD context). Often misdiagnosed; some patients have both OCD and BDD.
• Trichotillomania and Excoriation Disorder: Focused repetitive behaviors usually done automatically without obsessional content; treated differently (habit reversal, acceptance-commitment therapy); can co-occur with OCD.
• Hoarding Disorder: Now separate DSM-5 diagnosis though frequently comorbid with OCD.
• Tic Disorders: Tics are brief, purposeless movements; obsessions are thoughts. ~10-15% of OCD patients have comorbid tics; requires separate assessment.
• Obsessive-Compulsive Personality Disorder (OCPD): Ego-syntonic perfectionism; lacks intrusive obsessions or compulsions causing distress (OCPD is a personality style; OCD is a disorder).
• Psychotic Disorders: Delusions in schizophrenia are ego-syntonic and not resisted; O

Initial assessment and stabilization

• Risk triage first: screen for suicidal ideation and comorbid major depression, which drive most acute risk. Ego-dystonic harm or taboo obsessions are not homicidal ideation and do not by themselves justify involuntary hospitalization — reassurance plus treatment, not containment, is the correct response.
• Severity anchoring: baseline Y-BOCS establishes severity and is repeated to define response (conventionally a substantial percentage reduction in score plus functional gain).

First-line therapy (APA Practice Guideline for the Treatment of Patients With Obsessive-Compulsive Disorder)

• **Cognitive-behavioral therapy with *exposure and response prevention (ERP)***: the psychotherapy of choice; deliberate exposure to the trigger while blocking the ritual permits extinction learning in ventromedial prefrontal–amygdala circuits. Preferred as monotherapy in mild disease and in children (AACAP practice parameter).
• SSRIs: fluoxetine, sertraline, fluvoxamine, and paroxetine carry FDA approval for OCD; escitalopram is used off-label. Two mechanistic exam points: OCD requires higher doses than depression, and the latency to response is longer (roughly 8–12 weeks at maximal tolerated dose) before a trial is called failed.
• Combination SSRI + ERP for moderate-to-severe disease or significant comorbidity.

Escalation and second-line

• Switch to a second SSRI after an adequate failed trial.
• Clomipramine: the most serotonergic TCA and the only TCA effective in OCD; comparable efficacy to SSRIs but relegated to second-line by anticholinergic burden, orthostasis, QT prolongation, and dose-dependent seizure risk.
• Antipsychotic augmentation: low-dose aripiprazole or risperidone added to an SSRI, with the best evidence in tic-related OCD.
• Intensive/residential ERP for refractory or housebound patients; glutamate modulators (memantine, riluzole) remain investigational.

Neuromodulation and neurosurgery

• Deep TMS targeting medial prefrontal/anterior cingulate cortex is FDA-cleared for refractory OCD.
• Deep brain stimulation of the ventral capsule/ventral striatum is available under an FDA humanitarian device exemption; ablative anterior capsulotomy or cingulotomy is a last resort at specialized centers.

Avoid

• Benzodiazepine monotherapy: relieves anxiety without touching obsessions and undermines ERP by functioning as a safety behavior.
• MAOI combined with an SSRI or clomipramine: serotonin syndrome; a washout is mandatory.
• Clomipramine with recent MI or conduction disease; citalopram above the FDA-labeled maximum because of QT prolongation, a real limit when high doses are needed.

Complications of the disease

• Suicide and comorbid major depression: OCD carries elevated suicide risk, mediated largely by comorbid depression, hopelessness, and shame over taboo obsessions. Signalled by new hopelessness, withdrawal, or disclosure of intent — an emergency requiring immediate risk assessment and possible hospitalization.
• Irritant/contact dermatitis and skin breakdown: repetitive washing strips the epidermal barrier. Look for erythematous, fissured, sometimes secondarily infected hands and forearms; cellulitis is the complication to watch for.
• Nutritional and medical neglect: severe contamination or swallowing-related obsessions can cause food/fluid avoidance with weight loss, dehydration, and prerenal azotemia — occasionally severe enough to warrant admission.
• Family accommodation: relatives perform or facilitate rituals, which reinforces avoidance and predicts poorer ERP response. The signal is a caregiver describing hours spent providing reassurance.
• Occupational and academic collapse, substance use: alcohol or benzodiazepine misuse as self-medication compounds impairment.

Complications of treatment

• Serotonin syndrome: risk rises with SSRI plus clomipramine, MAOIs, triptans, linezolid, or tramadol. Triad of altered mentation, autonomic instability, and neuromuscular hyperexcitability with lower-extremity–predominant clonus and hyperreflexia — an emergency: stop serotonergic agents, aggressive cooling and benzodiazepines, cyproheptadine in severe cases.
• Treatment-emergent suicidality in patients under 25: FDA boxed warning for all antidepressants; mandates close early monitoring after initiation or dose increase.
• SSRI adverse effects: sexual dysfunction (a leading cause of nonadherence), GI upset, activation, SIADH with hyponatremia in the elderly, and bleeding risk with concurrent NSAIDs/anticoagulants. Abrupt stop of short half-life agents (paroxetine, fluvoxamine) causes a discontinuation syndrome with flu-like symptoms and electric-shock paresthesias — fluoxetine's long half-life makes this rare.
• Clomipramine toxicity: anticholinergic delirium, urinary retention, orthostatic hypotension, dose-dependent seizures, and QT prolongation. Overdose is an emergency — widened QRS from sodium-channel blockade is treated with IV sodium bicarbonate.
• Drug interactions: fluvoxamine is a potent CYP1A2 inhibitor, raising clozapine, theophylline, and clomipramine levels.
• Antipsychotic augmentation: weight gain and metabolic syndrome, akathisia (may be mistaken for worsening anxiety), and tardive dyskinesia with prolonged use.
• Neurosurgical/DBS complications: intracranial hemorrhage, infection, and stimulation-induced hypomania or personality change.

• Ego-dystonic versus ego-syntonic is the whole distinction: OCD patients are distressed by their thoughts and recognize them as their own and excessive; OCPD patients see their perfectionism and rigidity as correct and are untroubled by it. OCPD is a personality disorder with no true obsessions or compulsions — the single most tested distractor on this topic.
• Best next step in a new diagnosis: start an SSRI plus CBT with exposure and response prevention, per the APA practice guideline. If the stem offers "benzodiazepine" or "reassurance that the thoughts are untrue," both are wrong — reassurance is itself a compulsion.
• Dose and time: OCD needs higher SSRI doses and a longer trial (about 8–12 weeks at maximum tolerated dose) than depression. A vignette showing "no improvement after 3 weeks" calls for continuing and titrating, not switching.
• Clomipramine is the one TCA that works in OCD (most serotonergic). It is second-line because of anticholinergic effects, QT prolongation, and dose-dependent seizures; in overdose, a wide QRS is treated with sodium bicarbonate.
• The association examiners love: tic disorder / Tourette syndrome co-occurs with OCD in a meaningful minority, is a poor-prognosis marker, and is the setting where antipsychotic augmentation (aripiprazole, risperidone) has its best evidence.
• Abrupt-onset OCD plus tics in a school-age child after streptococcal pharyngitis = PANDAS; check antistreptococcal titers, though the entity remains controversial and treatment is standard OCD care.
• Harm obsessions are not homicidal ideation: a patient terrified of stabbing his infant, who hides knives and avoids the baby, has OCD — the correct answer is treatment and reassurance about diagnosis, not psychiatric hold or child-protective referral.
• Do not mistake mental rituals for absent compulsions: "Pure O" patients count, pray, or mentally review; the diagnosis and ERP-based treatment are unchanged.
• Refractory disease pathway: switch SSRI → clomipramine → antipsychotic augmentation → intensive ERP → deep TMS → DBS. Never MAOI plus SSRI (serotonin syndrome).